Health TrialsbyHealthPanel

Comparison of Posterior QLB and QIPB in Pediatric Undescended Testis Surgery.

ConditionsPostoperative PainCryptorchidism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age1-7
SponsorMedipol University

About this trial

This randomized, double-blind study compares the postoperative analgesic efficacy of ultrasound-guided Posterior Quadratus Lumborum Block (QLB) versus Quadroiliac Plane Block (QIPB) in pediatric patients aged 1-7 years undergoing unilateral undescended testis surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male pediatric patients aged 1-7 years.

ASA physical status I or II.

Scheduled for unilateral undescended testis surgery.

Written informed consent obtained.

Disqualifiers

History of neurological deficit or developmental delay.

Bleeding diathesis or known coagulopathy.

History of allergy to local anesthetics.

Infection or skin lesion at the block injection site.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-guided Posterior Quadratus Lumborum Block.

    Procedure/Surgery

    Patients will be placed in the lateral decubitus position. Under ultrasound guidance, the probe will be placed at the posterior axillary line. The needle will be advanced to the posterior fascial plane of the quadratus lumborum muscle. A total of 0.5 mL/kg of 0.25% Bupivacaine will be injected.

  • Ultrasound-guided Quadroiliac Plane Block

    Procedure/Surgery

    Patients will be placed in the lateral decubitus position. Under ultrasound guidance, the probe will be placed at the level of the iliac crest. The needle will be targeted to the plane where the quadratus lumborum muscle attaches to the iliac bone. A total of 0.5 mL/kg of 0.25% Bupivacaine will be injected

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Posterior QLB GroupExperimental treatment 1 intervention
Group B: QIPB GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Score (FLACC) at 12 Hours

Pain severity assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale. The total score ranges from 0 to 10, where higher scores indicate worse pain.

Time frame
12 hours post-surgery.

Secondary outcomes

1

Time to First Rescue Analgesic Request.

Time in minutes from surgery completion to the first dose of rescue analgesia.

Time frame
Up to 24 hours.
2

Total Postoperative Analgesic Consumption

Cumulative amount of rescue analgesics consumed (mg).

Time frame
24 hours post-surgery.
3

Incidence of Postoperative Complications.

Assessment of complications such as urinary retention, motor block, hematoma, or ecchymosis at the injection site.

Time frame
Up to 24 hours.
4

Postoperative Pain Scores (FLACC) at Other Time Points.

Pain severity assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at 30 minutes, 1, 2, 4, 6, and 24 hours. The total score ranges from 0 to 10, where higher scores indicate worse pain.

Time frame
30 minutes, 1, 2, 4, 6, and 24 hours post-surgery.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medipol University

Lead sponsor

Biruni University

Collaborator

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Collaborator

Source ClinicalTrials.gov
Apply now